Last10K.com

Immutep Ltd (IMMP) SEC Filing 6-K Foreign Issuer report for the period ending Wednesday, March 6, 2019

Immutep Ltd

HISTORY TOOLS
CIK: 1506184 Ticker: IMMP

View differences made from one to another to evaluate Immutep Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Immutep Ltd.

Continue

Assess how Immutep Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Immutep Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Immutep Ltd provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: IMMP
CIK: 1506184
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-19-065883
Submitted to the SEC: Wed Mar 06 2019 7:00:03 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/immp/0001193125-19-065883.htm